JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

The Ralstonia solanacearum effector RipAK suppresses plant hypersensitive response by inhibiting the activity of host catalases.

The destructive bacterial pathogen Ralstonia solanacearum delivers effector proteins via a type-III secretion system for its pathogenesis of plant hosts. However, the biochemical functions of most of these effectors remain unclear. RipAK of R. solanacearum GMI1000 is a type-III effector with unknown functions. Functional analysis demonstrated that in tobacco leaves, ripAK knockout bacteria produced an obvious hypersensitive response; also, infected tissues accumulated reactive oxygen species in a shorter period postinfection, compared with wild type. This strongly indicates that RipAK can inhibit hypersensitive response during infection. Further analysis showed that RipAK localizes to peroxisomes and interacts with host catalases (CATs) in plant cells. Truncation of 2 putative domains of RipAK caused it to fail to target the peroxisome and fail to interact with AtCATs, suggesting that RipAK localization depends on its interaction with CATs. Furthermore, heterologous expression of RipAK inhibited CAT activity in vivo and in vitro. Finally, compared with the ripAK mutant, infection with a bacterial strain overexpressing RipAK inhibited the transcription of many immunity-associated genes in infected tobacco leaves at 2- and 4-hr postinfection, although mRNA levels of NtCAT1 were upregulated. These data indicate that GMI1000 suppresses hypersensitive response by inhibiting host CATs through RipAK at early stages of infection.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app